Named on 12 rounds in the feed, most often at Series D+ and in Energy.
Rounds from 2022-12-15 to 2026-10-08
ROUNDS
12
led 2, joined 10
LED ROUNDS · USD
$117.2M
across 2 rounds
CO-INVESTORS
122
most often with Khosla Ventures
Named on 12 rounds in the feed, most often at Series D+ and in Energy.
Rounds from 2022-12-15 to 2026-10-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Veir A superconducting power delivery systems developer | Series C Verified against 1 of 30 sources | $110M | 2026-10-08 | [ PART ] |
Hertha Metals A steel company | Series A Verified against 1 of 26 sources | $133.7M | 2026-09-29 | [ PART ] |
Mazama Energy A geothermal energy developer specializing in superhot rock geothermal power | Series B Verified against 4 of 16 sources | $135M | 2026-09-17 | [ PART ] |
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series E Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $188M | 2026-08-06 | [ PART ] |
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2026-06-15 | [ PART ] |
Glydways Glydways sells autonomous vehicle transit solutions for urban mobility targeting city planners and transit authorities. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $170M | 2026-04-14 | [ PART ] |
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $257M | 2026-01-28 | [ PART ] |
Neurophos Neurophos builds photonic AI processors — the T100 OPU delivers exaflop-scale inference at a fraction of GPU power. | Series A Verified against 1 of 8 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $110M | 2026-01-22 | [ LEAD ] |
Commonwealth Fusion Systems Commonwealth Fusion Systems sells advanced fusion energy technology, particularly high-temperature superconducting magnets and fusion power plants, targeting energy providers and stakeholders in the clean energy sector. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $863M | 2025-08-28 | [ PART ] |
Mainspring Energy Mainspring Energy sells linear generators for flexible, low-emissions power solutions to businesses across various industries. | Series F Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $258M | 2025-04-14 | [ PART ] |
Neurophos Neurophos builds photonic AI processors — the T100 OPU delivers exaflop-scale inference at a fraction of GPU power. | Seed Verified against 2 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $7.2M | 2023-12-14 | [ LEAD ] |
Synchron They build implantable Brain-Computer Interfaces to restore communication and independence for people living with paralysis. | Series C Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2022-12-15 | [ PART ] |